South Korea places a strong emphasis on workplace safety, particularly in industries with safety-sensitive roles. Regulatory bodies mandate drug testing in certain sectors to ensure a safe working environment. Compliance with these regulations has driven the demand for drug screening services. The South Korean government actively addresses substance abuse issues through public health initiatives and legal measures. Government-supported campaigns raise awareness about the consequences of drug abuse, fostering a societal stance against illicit substances and contributing to increased demand for drug screening services. Many South Korean companies, especially those in safety-critical industries, enforce zero-tolerance policies for drug use in the workplace. Periodic drug testing is conducted as part of these policies to detect and deter substance abuse, contributing to the growth of the drug screening market. There is a growing awareness of the negative impact of substance abuse on individuals and society. This awareness has led to proactive measures by employers to implement drug testing programs as part of their broader commitment to employee well-being. The expansion of high-risk industries, including construction, manufacturing, and transportation, contributes to the growth of the drug screening market. As these sectors grow, so does the need for stringent safety measures, including regular drug testing. The availability of advanced drug testing technologies has made the screening process more accurate, efficient, and convenient. Continuous technological advancements attract businesses looking for reliable and up-to-date testing methods, stimulating market growth. The implementation of random drug testing programs in workplaces enhances the effectiveness of overall drug screening initiatives. Random testing is often seen as a powerful deterrent, encouraging employees to remain drug-free and contributing to the market's expansion. With a growing awareness of prescription drug misuse, employers are expanding drug testing programs to include a broader range of substances. This adaptability to emerging substance abuse trends ensures the relevance and effectiveness of drug screening services.
According to the research report "South Korea Drug Screening Market Overview, 2028," published by Bonafide Research, the South Korea Drug Screening market is expected to add more than USD 150 Million from 2023 to 2028. Wearable devices equipped with biosensors are being explored for continuous monitoring of substance levels. While not yet widely adopted, these technologies have the potential to revolutionize on-going monitoring, especially in safety-critical roles. Drug testing programs are increasingly being customized to cater to different workforce demographics. This includes tailoring programs for various age groups, understanding the unique challenges each group faces concerning substance abuse. Drug testing is increasingly integrated with broader occupational health programs. This includes regular health check-ups and screenings, emphasizing a comprehensive approach to employee health and well-being. Some employers are forming partnerships with rehabilitation centers and treatment facilities. This collaborative approach aims to provide support and assistance to employees identified through drug testing, emphasizing rehabilitation over punitive measures. Artificial intelligence (AI) is being explored for result analysis in drug testing. AI algorithms can process large datasets efficiently, identify patterns, and contribute to more accurate result interpretation, especially in high-volume testing scenarios. Mobile testing units are becoming more prevalent, especially in industries with a dispersed workforce. These units offer flexibility and convenience in conducting drug testing at various locations, including remote sites.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Analytical instruments offer a high level of precision and accuracy in detecting drugs and their metabolites in biological samples. The reliability of analytical results is crucial, especially in contexts where legal or medical decisions are based on drug screening outcomes. Analytical instruments can analyze a broad spectrum of drugs and substances. This capability is important for comprehensive drug screening programs that need to cover a wide range of substances, including both common drugs of abuse and emerging substances. Analytical instruments can analyze a broad spectrum of drugs and substances. This capability is important for comprehensive drug screening programs that need to cover a wide range of substances, including both common drugs of abuse and emerging substances. Analytical instruments can analyze a broad spectrum of drugs and substances. This capability is important for comprehensive drug screening programs that need to cover a wide range of substances, including both common drugs of abuse and emerging substances. Furthermore the market is segmented into Laboratories, Workplaces, Hospitals and Others Based on end user, Hospitals play a central role in providing integrated healthcare services, and drug screening is an essential component of patient care. The inclusion of drug screening services within hospital facilities aligns with a holistic approach to patient well-being. Drug screening in hospitals is essential for emergency room admissions, where quick and accurate assessments of patients' drug use may be necessary for immediate medical decisions. Rapid screening in emergency settings aids in prompt and appropriate medical interventions. Drug screening in hospitals is essential for emergency room admissions, where quick and accurate assessments of patients' drug use may be necessary for immediate medical decisions. Rapid screening in emergency settings aids in prompt and appropriate medical interventions.
The Breath Samples segment is experiencing notable growth in the South Korea drug screening market, driven by several key factors. Offering a non-invasive collection method, breath samples have gained popularity for their convenience, contributing to increased acceptance among individuals undergoing testing. The rapid testing capabilities of breath samples, providing immediate results, make them particularly advantageous in diverse settings such as workplaces, law enforcement, and healthcare, where quick decision-making based on drug screening outcomes is crucial. Technological advancements in breathalyzer technology have enhanced the accuracy and reliability of breath sample testing, with modern devices designed to detect a wide range of substances. This versatility in substance detection, coupled with the ability to identify recent drug use, positions breathe samples as a valuable method for comprehensive drug screening programs. The integration of breath sample testing with alcohol testing using portable and handheld devices further adds to its practicality and accessibility, especially in scenarios like roadside drug screening by law enforcement. Moreover, the adoption of breath sample testing in workplace programs, public health initiatives, and employee education efforts highlights its role in promoting a drug-free environment. Overall, the growth of the Breath Samples segment underscores its effectiveness, convenience, and versatility in addressing the evolving needs of drug screening in South Korea.
Considered in this report:
• Geography: South Korea
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
Aspects covered in this report:
• South Korea Drug Screening market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product and Service
• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service
By Sample Type
• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
By End User
• Laboratories
• Workplaces
• Hospitals
• Others
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.
Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
Table of Contents
1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
2.7. Geography
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. South Korea Macro Economic Indicators
5. Market Dynamics
5.1. Key Findings
5.2. Key Developments - 2021
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Covid-19 Effect
5.7. Supply chain Analysis
5.8. Policy & Regulatory Framework
5.9. Industry Experts Views
6. South Korea Drug Screening Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast By Product and Service
6.3. Market Size and Forecast By Sample Type
6.4. Market Size and Forecast By End User
7. South Korea Drug Screening Market Segmentations
7.1. South Korea Drug Screening Market, By Product and Service
7.1.1. South Korea Drug Screening Market Size, By Consumables, 2017-2028
7.1.2. South Korea Drug Screening Market Size, By Analytical Instruments, 2017-2028
7.1.3. South Korea Drug Screening Market Size, By Rapid Testing Devices, 2017-2028
7.1.4. South Korea Drug Screening Market Size, By Drug Screening Service, 2017-2028
7.2. South Korea Drug Screening Market, By Sample Type
7.2.1. South Korea Drug Screening Market Size, By Urine Samples, 2017-2028
7.2.2. South Korea Drug Screening Market Size, By Breath Samples, 2017-2028
7.2.3. South Korea Drug Screening Market Size, By Hair Samples, 2017-2028
7.2.4. South Korea Drug Screening Market Size, By Oral Fluid Samples, 2017-2028
7.2.5. South Korea Drug Screening Market Size, By Other Samples, 2017-2028
7.3. South Korea Drug Screening Market, By End User
7.3.1. South Korea Drug Screening Market Size, By Laboratories, 2017-2028
7.3.2. South Korea Drug Screening Market Size, By Workplaces, 2017-2028
7.3.3. South Korea Drug Screening Market Size, By Hospitals, 2017-2028
7.3.4. South Korea Drug Screening Market Size, By Others, 2017-2028
8. South Korea Drug Screening Market Opportunity Assessment
8.1. By Product and Service, 2023 to 2028
8.2. By Sample Type, 2023 to 2028
8.3. By End User, 2023 to 2028
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.1.1. Company Snapshot
9.2.1.2. Company Overview
9.2.1.3. Financial Highlights
9.2.1.4. Geographic Insights
9.2.1.5. Business Segment & Performance
9.2.1.6. Product Portfolio
9.2.1.7. Key Executives
9.2.1.8. Strategic Moves & Developments
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer
List of Table
Table 1 : Influencing Factors for Global Drug Screening Market, 2022
Table 2: South Korea Drug Screening Market Size and Forecast By Product and Service (2017, 2022 & 2028F)
Table 3: South Korea Drug Screening Market Size and Forecast By Sample Type (2017, 2022 & 2028F)
Table 4: South Korea Drug Screening Market Size and Forecast By End User (2017, 2022 & 2028F)
Table 5: South Korea Drug Screening Market Size of Consumables (2017 to 2028) in USD Million
Table 6: South Korea Drug Screening Market Size of Analytical Instruments (2017 to 2028) in USD Million
Table 7: South Korea Drug Screening Market Size of Rapid Testing Devices (2017 to 2028) in USD Million
Table 8: South Korea Drug Screening Market Size of Drug Screening Service (2017 to 2028) in USD Million
Table 9: South Korea Drug Screening Market Size of Urine Samples (2017 to 2028) in USD Million
Table 10: South Korea Drug Screening Market Size of Breath Samples (2017 to 2028) in USD Million
Table 11: South Korea Drug Screening Market Size of Hair Samples (2017 to 2028) in USD Million
Table 12: South Korea Drug Screening Market Size of Oral Fluid Samples (2017 to 2028) in USD Million
Table 13: South Korea Drug Screening Market Size of Other Samples (2017 to 2028) in USD Million
Table 14: South Korea Drug Screening Market Size of Laboratories (2017 to 2028) in USD Million
Table 15: South Korea Drug Screening Market Size of Workplaces (2017 to 2028) in USD Million
Table 16: South Korea Drug Screening Market Size of Hospitals (2017 to 2028) in USD Million
Table 17: South Korea Drug Screening Market Size of Others (2017 to 2028) in USD Million
List of Figures
Figure 1: South Korea Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 2: Market Attractiveness Index, By Product and Service
Figure 3: Market Attractiveness Index, By Sample Type
Figure 4: Market Attractiveness Index, By End User
Figure 5: Porter's Five Forces of South Korea Drug Screening Market
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More